Veraxa Biotech AG (VRXAW) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

Veraxa Biotech AG (VRXAW) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.1M, listed on NASDAQ, carrying a beta of 0.43 to the broader market. Veraxa Biotech AG is a clinical-stage biopharmaceutical company specializing in next-generation antibody-based cancer therapies. Led by Christoph Antz, public since 2026-06-10.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for VRXAW as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →